Brookline Capital Management Forecasts MNPR Q1 Earnings
Monopar Therapeutics Inc. (NASDAQ:MNPR – Free Report) – Research analysts at Brookline Capital Management raised their Q1 2025 earnings per share (EPS) estimates for Monopar Therapeutics in a report issued on Wednesday, February 5th. Brookline Capital Management analyst K. Dolliver now forecasts that the company will post earnings of ($0.68) per share for the quarter, […]
![Brookline Capital Management Forecasts MNPR Q1 Earnings](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/monopar-therapeutics-inc-logo-1200x675.png&w=240&h=240&zc=2)